NICEs independent appraisal committee has recommended that semaglutide can be offered as an option for weight management, alongside a reduced-calorie diet and increased physical activity in adults, only if: they have at least one weight-related comorbidity and: a BMI at least 35.0 kg/m2, or exceptionally, a BMI of 30.0 kg/m2 to 34.9 kg/m2 if they are referred to tier 3 services based on the criteria in NICEs clinical guideline on obesity: identification, assessment and management
Top hot oatmeal, protein pancakes, or whole grain waffles with a dollop of yogurt
Translating Results to Pounds For men at various starting weights, using the 15% average: Starting at 220 pounds: Average expected loss: 33 pounds End weight: 187 pounds High responder (20%+): Could reach 176 pounds or lower Starting at 250 pounds: Average expected loss: 37-38 pounds End weight: 212-213 pounds High responder: Could reach 200 pounds or lower Starting at 280 pounds: Average expected loss: 42 pounds End weight: 238 pounds High responder: Could reach 224 pounds or lower Starting at 300 pounds: Average expected loss: 45 pounds End weight: 255 pounds High responder: Could reach 240 pounds or lower These are approximations based on average results
Contrast that with a patient eating a varied omnivorous diet with no B12 risk factors who receives the same formulation
B-12 is necessary for maintaining healthy brain function
